FLIPI and FLIPI-2
| Risk factors . | Risk group . | No. of factors . | Outcome, % . | |
|---|---|---|---|---|
| 5-y OS | 10-y OS | |||
| FLIPI | Low | 0-1 | 91 | 71 |
| Age ≥60 y | ||||
| Stage III/IV | Intermediate | 2 | 78 | 51 |
| Hemoglobin <12 g/dL | ||||
| LDH elevated | High | 3-5 | 53 | 36 |
| >4 nodal sites | ||||
| 3-y PFS | 5-y PFS | |||
| FLIPI-2 | Low | 0 | 91 | 80 |
| Age ≥60 y | ||||
| B2M elevated | Intermediate | 1-2 | 69 | 51 |
| Hemoglobin < 2 g/dL | ||||
| BM involvement | High | 3-5 | 51 | 19 |
| Lymph node diameter >6 cm | ||||
| Risk factors . | Risk group . | No. of factors . | Outcome, % . | |
|---|---|---|---|---|
| 5-y OS | 10-y OS | |||
| FLIPI | Low | 0-1 | 91 | 71 |
| Age ≥60 y | ||||
| Stage III/IV | Intermediate | 2 | 78 | 51 |
| Hemoglobin <12 g/dL | ||||
| LDH elevated | High | 3-5 | 53 | 36 |
| >4 nodal sites | ||||
| 3-y PFS | 5-y PFS | |||
| FLIPI-2 | Low | 0 | 91 | 80 |
| Age ≥60 y | ||||
| B2M elevated | Intermediate | 1-2 | 69 | 51 |
| Hemoglobin < 2 g/dL | ||||
| BM involvement | High | 3-5 | 51 | 19 |
| Lymph node diameter >6 cm | ||||